Form 4: CVS Health Director Anne A. Finucane Reports Changes in Beneficial Ownership

Director Anne A. Finucane reports acquisition of share credits and updates to direct and indirect ownership of CVS Health Corp stock.

Summary

• On May 16, 2024, Anne A. Finucane, a director of CVS Health Corp, reported changes in her beneficial ownership of the company's stock.
• She acquired 2,184.0229 share credits due to deferral of a semi-annual retainer under the 2017 Incentive Compensation Plan.
• The price of the share credits was $57.52.
• Following the transaction, Finucane directly owns 7,232.2482 shares of common stock.
• She also indirectly owns 25,198 shares through the Finucane Family Trust and 9,747.6598 share credits representing deferred stock compensation.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating neutral sentiment. It reports routine transactions related to director compensation.

Positives

• The acquisition of share credits indicates continued alignment of the director's interests with the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the holdings of a director at CVS Health, which is typical activity.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Directors at companies like Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also routinely file Form 4s to report changes in their beneficial ownership.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the holdings of a company director.
• It assures stakeholders that directors' interests are aligned with the company's performance through equity ownership.

Key Dates